SCAI 2021: Comparison of the ISCHEMIA Trial Population to Patients Undergoing PCI in U.S. Practice: A CathPCI NCDR Research to Practice (R2P) Initiative


Saurav Chatterjee, MD
Principal Investigator; Assistant Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; Long Island Jewish Hospital/Northwell Health, New York

Saurav Chatterjee, MD, describes a cross-sectional analysis of National Cardiovascular Data Registry (NCDR) CathPCI Registry patients undergoing percutaneous coronary intervention (PCI) for stable ischemic heart disease in routine clinical practice. This analysis sought to evaluate the proportion of stable ischemic heart disease patients falling within the ISCHEMIA trial enrollment criteria. NCDR data were reviewed from the period of October 2017 to June 2019, an interval similarly representative and inclusive of the ISCHEMIA enrollment time period. These data were first presented at the 2021 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions. Read more.